Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
Published Online: 2015-04-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Anne S Tsao•Christian Manegold•Dean Fennell•Gregory M Lubiniecki•Gunnar Hillerdal•Hedy L Kindler•Hilary Calvert•Jean-Jacques Lafitte•Kazuya Fukuoka•Lee M Krug•Margaret Smith•Paul Baas•Quincy Chu•Rabab M Gaafar•Ronny Öhman•Ruth Plummer•Wieneke A Buikhuisen•Wilfried E E Eberhardt•Xing Sun
